GLPPal helps you log when Mounjaro-related nausea starts, how long it lasts and whether it follows dose changes — on the same timeline as your weekly tirzepatide injections.
Nausea is among the most commonly reported side effects during Mounjaro titration. Tirzepatide affects gastric emptying and appetite signals, which can leave you feeling queasy — especially in the first days after a dose increase. Because Mounjaro is injected weekly, nausea may cluster around injection day or build toward your next dose. A Mounjaro-specific nausea log captures timing your memory alone cannot reliably reconstruct weeks later.
This nausea tracker works alongside the main Mounjaro Tracker App where injections, weight and appetite live on one timeline.
Explore other Mounjaro symptom tools or return to the Mounjaro Constipation Tracker, Mounjaro Fatigue Tracker, and GLP-1 trackers hub to compare every tracker.
Many people report nausea during early weeks or after dose increases on tirzepatide. Experiences vary widely. GLPPal helps you record your personal pattern — it does not assess whether your symptoms are normal or need urgent care. Contact your clinician about persistent or severe nausea.
Download on the App Store to log nausea, injections, appetite and weight for Mounjaro in one app.
GLPPal is designed for tracking and educational purposes only and is not medical advice.